MetaADEDB 2.0 @ LMMD
naloxegol
(XNKCCCKFOQNXKV-ZRSCBOBOSA-N)
Structure
SMILES
COCCOCCOCCOCCOCCOCCOCCO[C@H]1CC[C@@]2([C@@]34[C@H]1Oc1c4c(C[C@H]2N(CC3)CC=C)ccc1O)O
Type(s)
Approved
ATC code(s)
A06AH03
Molecular Formula:
C34H53NO11
Molecular Weight:
651.785
Log P:
1.8014
Hydrogen Bond Acceptor:
12
Hydrogen Bond Donor:
2
TPSA:
126.77
CAS Number(s):
854601-70-0
Synonym(s)
1.
naloxegol
2.
Movantik
3.
NKTR-118
External Link(s)
MeSHC000589308
PubChem Compound56959087
ChEBI82975
CHEMBLCHEMBL2219418
DrugBankDB09049
DrugCentral4832
IUPHAR/BPS Guide to PHARMACOLOGY7539
KEGGdr:D10479
Therapeutic Target DatabaseD07LCF
ZINC95564694
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Abdominal PainFAERS: 73
Canada Vigilance: 1
Canada Vigilance
US FAERS
2NauseaFAERS: 57US FAERS
3PainFAERS: 53US FAERS
4ConstipationFAERS: 52US FAERS
5Intentional product misuseFAERS: 50US FAERS
6Drug withdrawal syndromeFAERS: 47US FAERS
7Drug ineffectiveFAERS: 45US FAERS
8VomitingFAERS: 32US FAERS
9ChillsFAERS: 31US FAERS
10Drug screen positiveFAERS: 29US FAERS
11MalaiseFAERS: 24US FAERS
12TremorFAERS: 22US FAERS
13Bowel movement irregularityFAERS: 19US FAERS
14Feeling abnormalFAERS: 19
Canada Vigilance: 1
Canada Vigilance
US FAERS
15FlatulenceFAERS: 19US FAERS
16AnxietyFAERS: 17US FAERS
17DizzinessFAERS: 13US FAERS
18Infrequent bowel movementsFAERS: 12US FAERS
19Product use issueFAERS: 12US FAERS
20Drug dose omissionFAERS: 10US FAERS
21Back PainFAERS: 9US FAERS
22HeadacheFAERS: 9US FAERS
23Product use in unapproved indicationFAERS: 9US FAERS
24Abdominal discomfortFAERS: 8
Canada Vigilance: 6
Canada Vigilance
US FAERS
25DehydrationFAERS: 7US FAERS
26AstheniaFAERS: 6US FAERS
27SomnolenceFAERS: 6US FAERS
28Weight decreasedFAERS: 6US FAERS
29Wrong technique in product usage processFAERS: 6US FAERS
30Blood glucose increasedFAERS: 5US FAERS
31ColitisFAERS: 5US FAERS
32FatigueFAERS: 5US FAERS
33Myocardial InfarctionFAERS: 5US FAERS
34Adverse eventFAERS: 4US FAERS
35Chest PainFAERS: 4US FAERS
36DiscomfortFAERS: 4US FAERS
37Gastrointestinal PainFAERS: 4US FAERS
38Intestinal ObstructionFAERS: 4US FAERS
39Muscle strainFAERS: 4US FAERS
40NervousnessFAERS: 4US FAERS
41Abdominal symptomFAERS: 3US FAERS
42Cold sweatFAERS: 3US FAERS
43CryingFAERS: 3US FAERS
44Drug administration errorFAERS: 3US FAERS
45DysgeusiaFAERS: 3US FAERS
46DyspepsiaFAERS: 3US FAERS
47Feeling jitteryFAERS: 3US FAERS
48Gastrointestinal motility disorderFAERS: 3US FAERS
49IleusFAERS: 3US FAERS
50Joint swellingFAERS: 3US FAERS
51Memory impairmentFAERS: 3US FAERS
52MyalgiaFAERS: 3US FAERS
53PalpitationsFAERS: 3US FAERS
54UrticariaFAERS: 3US FAERS
55AgitationFAERS: 2US FAERS
56Cerebrovascular accidentFAERS: 2US FAERS
57Circumstance or information capable of leading to medication errorFAERS: 2US FAERS
58Cluster HeadacheFAERS: 2US FAERS
59Diabetes mellitus inadequate controlFAERS: 2US FAERS
60Drug effect incompleteFAERS: 2US FAERS
61DysphoniaFAERS: 2US FAERS
62EructationFAERS: 2US FAERS
63Extra dose administeredFAERS: 2US FAERS
64Gastrointestinal hypermotilityFAERS: 2US FAERS
65Gastrointestinal hypomotilityFAERS: 2US FAERS
66HypersensitivityFAERS: 2US FAERS
67HypophagiaFAERS: 2US FAERS
68Inadequate analgesiaFAERS: 2US FAERS
69InfectionFAERS: 2US FAERS
70Intentional product use issueFAERS: 2US FAERS
71Intestinal PerforationFAERS: 2US FAERS
72Large intestine perforationFAERS: 2US FAERS
73Limb discomfortFAERS: 2US FAERS
74Lip swellingFAERS: 2US FAERS
75Mouth swellingFAERS: 2US FAERS
76Neck PainFAERS: 2US FAERS
77Night sweatsFAERS: 2US FAERS
78Opiates positiveFAERS: 2US FAERS
79PancreatitisFAERS: 2US FAERS
80Peripheral swellingFAERS: 2US FAERS
81Product dose omissionFAERS: 2US FAERS
82RetchingFAERS: 2US FAERS
83SwellingFAERS: 2US FAERS
84TachyphylaxisFAERS: 2US FAERS
85Therapeutic response unexpectedFAERS: 2US FAERS
86YawningFAERS: 2US FAERS
87Activities of daily living impairedFAERS: 1US FAERS
88AlopeciaFAERS: 1US FAERS
89AmnesiaFAERS: 1US FAERS
90AngerFAERS: 1US FAERS
91Anorectal discomfortFAERS: 1US FAERS
92AnorgasmiaFAERS: 1US FAERS
93ArthralgiaFAERS: 1US FAERS
94Autonomic failure syndromeFAERS: 1US FAERS
95Blood brain barrier defectFAERS: 1US FAERS
96Blood creatinine abnormalFAERS: 1US FAERS
97Blood creatinine increasedFAERS: 1US FAERS
98Blood iron decreasedFAERS: 1US FAERS
99Blood urea increasedFAERS: 1US FAERS
100Blood urine presentFAERS: 1US FAERS
101Bone painFAERS: 1US FAERS
102Burning sensationFAERS: 1US FAERS
103Cancer PainFAERS: 1US FAERS
104Carbohydrate intoleranceFAERS: 1US FAERS
105Cardiac FlutterFAERS: 1US FAERS
106Creatinine renal clearance decreasedFAERS: 1US FAERS
107DementiaFAERS: 1US FAERS
108Depressed Level of ConsciousnessFAERS: 1US FAERS
109DisorientationFAERS: 1US FAERS
110Disturbance in sexual arousalFAERS: 1US FAERS
111Drug ineffective for unapproved indicationFAERS: 1US FAERS
112Duodenal UlcerFAERS: 1US FAERS
113DystoniaFAERS: 1US FAERS
114DysuriaFAERS: 1US FAERS
115EpilepsyFAERS: 1US FAERS
116EpistaxisFAERS: 1US FAERS
117FibromyalgiaFAERS: 1US FAERS
118Food PoisoningFAERS: 1US FAERS
119FormicationFAERS: 1US FAERS
120GastritisFAERS: 1US FAERS
121Gastrointestinal candidiasisFAERS: 1US FAERS
122Gastrointestinal inflammationFAERS: 1US FAERS
123Gastrointestinal obstructionFAERS: 1US FAERS
124Gastrointestinal perforationFAERS: 1US FAERS
125GlaucomaFAERS: 1US FAERS
126HepatitisFAERS: 1US FAERS
127Hypertensive crisisFAERS: 1US FAERS
128Immune thrombocytopenic purpuraFAERS: 1US FAERS
129Impaired gastric emptyingFAERS: 1US FAERS
130Inappropriate schedule of product administrationFAERS: 1US FAERS
131Incorrect dose administeredFAERS: 1US FAERS
132InfluenzaFAERS: 1US FAERS
133Inhibitory drug interactionFAERS: 1US FAERS
134Intestinal Pseudo-ObstructionFAERS: 1US FAERS
135IntussusceptionFAERS: 1US FAERS
136Laboratory test interferenceFAERS: 1US FAERS
137Medication ErrorFAERS: 1US FAERS
138Medication residue presentFAERS: 1US FAERS
139Mental FatigueFAERS: 1US FAERS
140Metastatic NeoplasmFAERS: 1US FAERS
141MoaningFAERS: 1US FAERS
142Muscle tightnessFAERS: 1US FAERS
143Muscle tone disorderFAERS: 1US FAERS
144Musculoskeletal chest painFAERS: 1US FAERS
145Musculoskeletal discomfortFAERS: 1US FAERS
146MyoclonusFAERS: 1US FAERS
147NasopharyngitisFAERS: 1US FAERS
148Negative thoughtsFAERS: 1US FAERS
149NephrolithiasisFAERS: 1US FAERS
150NeuralgiaFAERS: 1US FAERS
151No adverse eventFAERS: 1US FAERS
152Oropharyngeal painFAERS: 1US FAERS
153OverdoseFAERS: 1US FAERS
154PallorFAERS: 1US FAERS
155Pancreatic carcinomaFAERS: 1US FAERS
156Panic DisorderFAERS: 1US FAERS
157Post procedural infectionFAERS: 1US FAERS
158PruritusFAERS: 1US FAERS
159QuadriplegiaFAERS: 1US FAERS
160Renal painFAERS: 1US FAERS
161Restless Legs SyndromeFAERS: 1US FAERS
162Rheumatoid ArthritisFAERS: 1US FAERS
163Serotonin SyndromeFAERS: 1US FAERS
164SinusitisFAERS: 1US FAERS
165Spinal column stenosisFAERS: 1US FAERS
166Tarsal Tunnel SyndromeFAERS: 1US FAERS
167Therapy cessationFAERS: 1US FAERS
168Therapy non-responderFAERS: 1US FAERS
169Throat irritationFAERS: 1US FAERS
170UlcerFAERS: 1US FAERS
171Umbilical herniaFAERS: 1US FAERS
172Urinary IncontinenceFAERS: 1US FAERS
173Wrong doseFAERS: 1US FAERS
174nervous system disorderFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120237

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.